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SPECIFICITY OF THE CYCLIC GMP-BINDING ACTIVITY AND OF A CYCLIC 
GMP-DEPENDENT CYCLIC GMP PHOSPHODIESTERASE IN 
Dktyostelium discoideum 
Peter J.M. van H~STERT, Hans van WALSH, Rob C. van der MEEK 
Roman BULGAKOV and Theo M. KONIJN 
Cell Biology and ~orphoge~e~‘s Unit, Zoological Laboratory, University of Leiden, 
Kaiserstreat 63, NL-2311 GP Leidea (The Netherlands) 
Received 5 May 1981; revision received 24 August 1981; accepted 11 September 1981 
The nucleotide specificity of the cyclic GMP-binding activity in a homogenate of Dicty- 
ostelium discoideum was determined by competition of cyclic GMP derivatives with [S-sH] - 
cyclic GMP for the binding sites. The results indicate that cyclic GMP is bound to the binding 
proteins by hydrogen bonds at N’Ha, Nr -H and/or Ce = 0, N’, 2*-OH and 3r-0 and possibly via 
a charge-charge interaction with the phosphate moiety of cyclic GMP. Cyclic AMP only com- 
petes with cyclic GMP for binding at a 20 000-fold higher concentration. 
The same cyclic GMP derivatives were used to modify the hydrolysis of [8-3H] cyclic GMP 
by phosphodiesterase. The phosphodiesterase is activated by cyclic GMP. The nucleotide 
specificity for activation of the enzyme differs from the specificity of the enzyme for hy- 
drolysis. This indicates that activation by cyclic GMP and hydrolysis of cyclic GMP occur at 
different sites of the enzyme. Cyclic AMP neither activates the cyclic GMP phosphodiesterase 
nor competes with cyclic GMP for hydrolysis. This indicates that intracellular cyclic AMP does 
not interfere with the action of intracellular cyclic GMP in D. discoideum. 
Keywords: cyclic GMP-dependent cGMP phosphodiesterase; cyclic GMP-binding protein; 
Dictyostelium discoideum; cyclic GMP derivatives. 
Vegetative cells of ~~e~yos~el~um ~~s~~~e~~ react chemota~tica~y with folic 
acid fl ] , which probably acts as a food-seeking device. A~regation-competent cells 
react chemotactically with cyclic AMP 121, which is excreted in pulses by neigh- 
Abbreviations: cyclic AMP or CAMP, adenosine 3’,5’-monophosphate; cyclic GMP or cGMP, 
guanosine 3’,5’-monophosphate; cIMP, inosine 3’,5’-monophosphate; cXMP, xanthosine 3’,5’- 
monophosphate; 8-BrcGMP, 8-bromoguanosine 3’,5’-monophosphate; %NHz-cGMP, 8-amino- 
guanosine 3’,5’-monophosphate; 8-OHcGMP, S-hydroxyguanosine 3’,5’-monophosphate; 8-BA- 
cGMP, 8-benzylaminoguanosine 3’,.5’-monophosphate; 8-M-cGMP, 8-morpholmoguanosine 
3’,5’-monophosphate; 2’-H-cGMP, 2’deoxyguanosine 3’,5’-monophosphate; 5’-GMP, guanosine 
S-monophosphate; Gus, guanosine; DTT, dithiothreitol; Tris, ~is(hydroxymethyl)~~o- 
methane. 
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boring cells [3]. Cyclic GMP levels are transiently elevated by cyclic AMP in aggrega- 
tive cells of D. discoideum [4,5], by folic acid in vegetative cells of D. discoideum 
[4,6], D. lacteum, D. minutum and Polysphondylium violaceum (Kakebeeke, 
personal communication), and by partly purified, active extracts, which specifically 
attract D. lacteum [7,8] and Polysphondylium violaceum [9,10]. Cyclic GMP may 
be either hydrolyzed by a cyclic nucleotide phosphodiesterase, or bound to intra- 
cellular proteins, thus transmitting the extracellular signal. 
Cyclic GMP-binding proteins have been found in several organisms [ 1 l-l 61 and 
are often not associated with protein kinase activity [l l-151. Also, the cyclic 
GMP-binding activity in homogenates of D. discoideum cells [17-191 seems not 
to be associated with cyclic GMP-dependent protein kinase activity [18,19] and can 
be divided into at least 3 fractions of different molecular weights [ 191. A cyclic 
nucleotide phosphodiesterase from a homogenate of D. discoideum is more specific 
for cyclic GMP than for cyclic,AMP, and expresses positive co-operativity [6]. 
Cyclic GMP-dependent cyclic GMP-specific phosphodiesterases also occur in other 
organisms [20-231. 
Unfortunately, the binding activity and the cyclic GMP-hydrolyzing activity of 
D. discoideum are unstable. (The half-life at optimal pH and ion concentration is 
not more than one day, and mostly less than 5 h.) To obtain more information on 
these 2 significant proteins, non-purified preparations have to be used. In this 
paper, we describe the cyclic nucleotide specificity of these proteins. The results 
show a high degree of specificity, especially in the purine moiety, indicating that 
intracellular cyclic AMP does not interact with these proteins. 
MATERIALS AND METHODS 
Materials 
Cyclic GMP, CAMP, cIMP, cXMP, 5’-GMP and guanosine were purchased from 
Boehringer, dithiothreitol (DTT), 2’-H-cGMP, and snake venom (Ophiophagus han- 
nah) were from Sigma, and [8-3H]-cyclic GMP (0.55 TBq/mmole; 1 TBp = 10” 
dps = 27 Ci) was from Amersham. 8-NH2-cGMP, 8-OH-cGMP, 8-BA-cGMP and 
8-M-cGMP (Fig. 1) were generously given by Dr. Mtihlegger, Boehringer. 
Culture conditions 
Dictyostelium discoideum, NW(H), was grown on SM-agar in association with 
Escherichia coli B/r [24]. Cells were harvested in 10 mM sodium-potassium phos- 
phate buffer (pH 6.0), and freed from bacteria by repeated washing and centrifuga- 
tion at 100 Xg for 4 min. Cells were starved by shaking in 10 mM phosphate buffer 
(pH 6.0) at a density of lo7 cells/ml. 
Homogenate 
For the cyclic GMP-binding experiments, cells were starved for 2 h, washed 
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[IMP-- 
tXMP CAMP E-OtkGMP 
Fig. 1. The structure of cyclic GMP and cyclic GMP derivatives. AU keto-enol equilibria are 
shown in the keto conformation. RcP, ribose 3’,5’-monophosphate. 
twice in the homogen~ation buffer (5 mM Tris-IICl, pH 7.5) and suspended at a 
density of 2 X 10s celYls/ml in the same buffer. Cells were homoge~zed at 0°C by 
sonic disruption,witha Branson B12 sonifier with microtip, twice for 5 set at 50 W. 
The homogenate was centrifuged at 0°C for 10 min at 30 000 Xg, and the super- 
natant for 3 h at 48 000 X g. The 48 000 X g supernatant was used for the experi- 
ments. For the phosphodiesterase xperiments the same procedure was followed, 
except that the homogenization buffer was 10 mM phosphate buffer (pH 7.0), the 
cell density was 5.X 107/ml, and sonication was carried out 3 times for 5 sec. 
Cyclic GMP-binding assay 
The incubation mixture at 0°C contained 50 mM phosphate buffer (pH 6.5), 
3 m&I MgS04, 2 mM DTT (Sigma), lo-’ M [8-3H]cychc GMP (0.55 T3q~~ole) 
(Amers~m), the 48 000 Xg supernatant and various concentrations of unlabeled 
cyclic GMP and cyclic GMP derivatives in a total volume of 250 pl. The incubations 
(in duplicate) were started by the addition of 100 1.~148 000 Xg supernatant, and 
terminated 10 min later by filtration of 200 I.LI over millipore filters (diameter 2.4 
cm, pore size 0.45 pm). Filters were washed twice with 4 ml 50 mM phosphate 
buffer, and transferred to 4 ml InstaGel (Packard). The radioactivity was deter- 
mined with an LKB Beta-rack liquid scintillation counter. 
Hydrolysis of [8-3H]cyclic GMP was negligible (<lo% per h) owing to the 
temperature and pH at which binding experiments were performed. 
The identity of bound radioactivity was determined by extraction of 7 filters 
with 10 ml H20, and ~~omatography of the extract by HPLC on Partisil lo-SAX 
with 50 mM KHZP04, 15% propanol-1, 5% methanol (pH 4.9) as mobile-phase 
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liquid. More than 90% of the radioactivity 
and not with guanosine, guanine or 5’-GMP. 
Phosphodiesterase assay 
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co-chromatographed with cyclic GMP 
Phosphodiesterase was assayed according to the method of Thompson et al. 
[26]. The 400-1.11 incubation mixture contained 10 mM phosphate buffer (pH 7.0), 
2.5 mM DTT, 1.0 mM MgS04, 2 kBq [8-3H]cyclic GMP, 48 000 Xg supernatant, 
and unlabeled cyclic GMP or one of the cyclic GMP derivatives. DTT, an inhibitor 
of non-specific phosphodiesterases in D. discoideum [25], was added to the ho- 
mogenate 15 min before the incubations [6]. The incubations (in duplicate) were 
started by the addition of 200 ~1 48 000 Xg supernatant at 22°C and terminated 
after 15 or 30 min by boiling for 2 min. The homogenate was cooled, 100 ~1 snake 
venom (100 pg) was added, and the mixture was incubated for 30 min at 22°C. 
The remaining [3H] cyclic GMP was removed by the addition of 1 ml anion-ex- 
changer (1 part AG-1-X2 in water plus 2 parts ethanol); 1.5 min later, samples were 
centrifuged at 8000 Xg for 2 mm. The radioactivity of 500 ~1 of the supernatant 
was measured. The hydrolysis of cyclic GMP at concentrations between 10e8 and 
10e4 M is linear with time, if hydrolysis remains below about 50%. The hydrolysis 
is linear with homogenate concentration as long as the enzyme concentration in the 
incubation mixture is no higher than the equivalent of IO’ cells/ml. 
RESULTS AND DISCUSSION 
Hydrogen bonds contribute significantly to the specificity of the binding of a 
ligand to a protein, because these interactions are energy-rich and dependent on the 
correct orientation of the dipoles. By selecting cyclic GMP derivatives (Fig. 1) in 
which such interactions cannot take place, it is possible to determine the atoms or 
atom groups of cyclic GMP that are directly involved in an interaction with the pro- 
H 0 L. ” “5’ ‘, 1 
0 id’0 168 16 10-4 
nuclotlde concen+rat,on (VI) 
Fig. 2. Inhibition of the binding of [8-sH] cyclic GMP by cyclic GMP and cyclic GMP deriva- 
tives. lo-9 M [8-sH] cyclic GMP was incubated with a 48 000 Xg supernatant and various 
concentrations of cyclic GMP or cyclic GMP derivatives for 10 min at 0°C; then the incubation 
mixture was filtered over millipore filters and the filter-associated radl’oactivity was determined. 
., cylic GMP; o, 8-BrcGMP; A., 2’-H-cGMP; 0, CAMP. 
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tein 127-2911; the involved atoms or atom groups of the protein, however, are not 
determined. 
Specificity oj‘the cyclic G&Pbinding activity 
The ambition of the binding of [3H]cyclic GMP by cyclic GMP, 8-Br-cGMP, 
2’-H-CC&E and CAMP is shown in Fig. 2. None of the derivatives revealed the 
existence of more than one binding protein with different specificity. The results 
are summarized in Table 1. In a few experiments (not included in Table 1) the 
binding of [3H]cycli~ GMP was reduced by 20-30% by the addition of 10m9 M 
cyclic nucle.otides, Since all derivatives showed this at the same low concentration, 
we consider this as non-specific saturable binding with high affinity [30]. This 
component is probably identical with peak II in ref. [19]. 
Kinetic experiments, in which the dissociation constant and the rate constants 
of association and dissociation were measured, have not given support to the 
existence of 2 different binding proteins ([ 171 and unpublished observations). 
We used the method of Jastorff et al. [27-291 to explain the results of Table 1. 




This change of free energy represents the reduction of binding energy between 
receptor and derivative as compared with cyclic G&P. 
Table 1 














Binding activity a) (nM) GAG(kJ/mole) 
.-I_ 
2.8 + 1.5 (14) 0 
580 ? 350 (5) 12.1 
2 800 f 1500 (6) 15.7 
56 000 t 16 000 (6) 22.5 
18 + 5 (6) 4.2 
22 2 7 (5) 4.7 
470 i 250 (5) 11.6 
6 900 d- 3 200 (6) 17.7 
5900+3610(6) 17.4 
450 ?I 141 (4) 11.5 
> 1000 000 b, (3) >29 
> 1000 000 b) (3) >20 
111 
‘1 Cyclic GMP-biding protein was incubated with 10-a M [%sH]cycIic GMP and different 
concentrations of various nucleotides. The concentration that results in 50% inhibition of 
the binding of [ fL3H]cyclic GMP to the specific component(s) is given as binding activity. 
Data in nM IL standard deviation and number of determinations in parentheses, 
b, No inhibition at 10-s M. 
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According to Gabler [32], the energy of interaction of a hydrogen bond is 
between 8 and 40 kJ/mole (2-10 kcal/mole). Arbitrarily, we suggest that 6AG 
values above 11 kJ/mole represent hydrogen bonds or charge-charge interactions, 
while 6AG values below 5 kJ/mole are thought to be derived from general stereo- 
chemical and electronic features that have been changed by the modification of the 
ligand. Jastorff et al. [27-291 have placed the arbitrary division at about FAG = 
l~.FkJ/mole .
Removal of the amino group at the 2 position (cGMP + cIMP) results in a 
change of binding energy of about 12.1 kJ/mole, indicating a hydrogen-bond inter- 
action between N2Hz and a hydrogen-bond acceptor of the protein. Addition of a 
hydroxyl group at the 2 position (cIMP+cXMP), which is in keto-enol tautome- 
rism with N3, does not reduce the binding activity essentially further. Because the 
keto form is probably favored [33,34], a hydrogen-bond interaction at N3 is un- 
likely. The 6AG of cyclic AMP is about 22.5 as compared with cyclic GMP and 
about 11.4 as compared with cIMP, probably indicating the existence of another 
hydrogen-bond interaction at Nr-H and/or C6 = 0 of cyclic GMP with the binding 
protein. 8-BrcGMP and 8-NH*-cGMP have binding energies comparable to cyclic 
GMP. Since bulky groups at the 8-position change the syn-anti equilibrium to syn 
[35], and since cyclic GMP itself exists predominantly in the syn conformation 
[36] we propose that cyclic GMP is bound in the syn conformation. Although 8- 
NH2-cGMP and 8-OH-cGMP are comparable in size and polarity, the binding 
energies differ significantly. This could be explained by the assumption that, in 
8-OH-cGMP, the keto-enol tautomerism of 8-OH with N7 exists predominantly 
in the keto conformation [33,34]. This results in a change of N7 from a hydrogen- 
bond acceptor (N’) into a hydrogen-bond donator (N’H). Therefore, we propose 
a hydrogen-bond interaction with the protein at N7. The low binding energy of 
8-BA-cGMP and 8-M-cGMP can be explained by the size of these bulky groups, and 
by the influence that these substitutents have on the electron distribution in the 
purine moiety. This may change the electron density at N’, N2H2, C? = 0 and N7 
and therefore also the energies of interactions of the hydrogen bonds at these po- 
sitions. 2’-H-cGMP shows a hydrogen-bond interaction at the 2’-OH position 5’- 
GMP and guanosine are inactive, which may indicate a hydrogen-bond interaction 
at the 3’-0 position and possibly a charge-charge interaction with phosphate. 
Information on the existence of a hydrogen bond at the 5’-0 position is not avail- 
able. 
As far as these analogs have been tested for cyclic GMP-dependent protein 
kinases [16], it is clear that the binding protein of D. discoideum is more specific. 
Specificity of the cyclic GMP-hydrolyzing activity 
The fraction of substrate hydrolyzed during a certain time by an enzyme with 
normal Michaelis-Menten kinetics is given by 
fraction hydrolyzed = A & = A (1) 
Cyclic GMP in Dictyostelium discoideum 
substrate cancentraf~on [M] 
Fig. 3. Demonstration of activation and inhibition of hydrolysis of cyclic GMP by cyclic GMP. 
Curves a and b are calculated for 2 enzymes with Michaelis-Menten kinetics. a, A V’,,,K,-’ = 
4 X lo-smin-‘, Km = 10-s M; b, AV~,,K,-’ = 12 X 10-3min-1, Km = lo5 M. (See text for 
explanation.) l , Various concentrations of cyclic GMP were incubated for 30 min with ho- 
mogenate, after which the hydrolyzed fraction was determined. 
where A is the proportionality constant. In Fig. 3 the hydrolysis of cyclic GMP at 
different substrate concentrations is presented as substrate concentration versus 
fraction hydrolyzed/mm, and compared with the activity of 2 enzymes with 
normal Michaelis-Menten kinetics. This figure shows that, at between lo-’ and 
10m6 M cyclic GMP, the phosphodiesterase is activated by cyclic GMP. At about 
3 X 10e6 M, activation seems to be completed; at higher substrate concentrations 
the enzyme follows normal Michaelis-Menten kinetics with an apparent K, of 
about 10e5 M. We shall use this plot to visualize the specificity of the activation and 
inhibition of the hydrolysis of [3H]~y~li~ GMP by cyclic GMP and cyclic GMP 
derivatives. 
The cyclic GMP phosphodiesterase described by Dicou and Brachet [37] has 
several characteristics in common with our enzyme preparation, such as high sub- 
strate specificity, activation by magnesium ions, calcium independency, and an 
apparent Michaelis-Menten constant at high substrate concentrations of 3-10 PM 
(Mato et al. [6], this report and data not shown). However, in the experiment of 
Dicou and Brachet [37], phosphodiesterase is not activated by cyclic GMP. This 
discrepancy is not due to the use of different strains, and probably also not because 
of different assay conditions; more likely it is due to the instability of the enzyme 
complex. 
Inhibition of the hydrolysis of cyclic GMP 
Addition of different concentrations of cyclic nucleotides to an incubation mix- 
ture containing 10T6 M [3H]~y~li~ GMP particularly shows the competition of 
these cyclic nucleotides with [3H]cyclic GMP for binding to the activated hydro- 
lysis site. Fig. 4 shows that activation of the phosphodiesterase is not yet complete 
at low6 M cyclic GMP (8-Br-cGMP, 8-NH2-cGMP, 8-BA-cGMP, and 8-OH-cGMP). 
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Fig. 4. Effect of cyclic GMP derivatives on the hydrolysis of 10-e M [sH] cyclic GMP. [aH] - 
cyclic GMP (10M6 M) was incubated with various concentrations (indicated on abscissa) of cyclic 
GMP, or cyclic GMP derivatives for 30 min, after which the fraction of hydrolyzed cyclic GMP 
was determined. All data are taken from 1 Expt.; duplicate experiments gave similar results. 
-+ * ’ 
26 
I 
I ,,l, , 
0 KP 16’ ld6 12 
roncentrat,on [M] 
Fig. 5. Effect of cyclic GMP derivatives on the hydrolysis of 10-s M [3H] cyclic GMP. [aH] - 
Cyciic GMP (10-a M) was incubated with variousconcentrations of cy$ic GMPor cyclic GMP 
derivatives for 15 or 30 mm, whereafter the fraction of cyclic GMP hydrolyzed was measured. 
8QH-cGMP, 8-NHacGMP, 8-BA-cGMP, 8-BrcGMP and cGMP were incubated for 15 min; 
cyclic GMP and other derivatives for 30 mm. All data are taken from 1 Expt. which was 
repeated twice, with similar results. 
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8-Br-cGMP and 8-NH,-cGMP inhibit the hydrolysis of [3H]~y~li~ GMP at concen- 
trations above 10m5 M, which is about 10 times higher than the concentration of 
cyclic GMP that causes inhibition. cIMP, cXMP and 2’-H-cGMP show strong inhibi- 
tion of the hydrolysis of cyclic GMP, indicating that N2Hz and 2’-OH are probably 
not directly involved in the interaction of cyclic GMP with the hydrolysis site of 
the activated enzyme. Cyclic AMP only slightly affects the hydrolysis of [3H] - 
cyclic GMP, which suggests that unspecific phosphodiesterases are blocked by DTT, 
and that N’-H and/or C6 = 0 are/is directly involved in binding to the hydrolytic 
site of the activated enzyme. 8-OH-cGMP is inactive as inhibitor. Assuming that the 
keto form is favored in purines [33,34] this may suggest a direct interaction at 
N’. Guanosine and 5’-GMP are inactive, which probably indicates direct inter- 
action at the phosphate and 3’-0. 
Activation of the hydrolysis of cyclic GMP 
Addition of cyclic nucleotides to incubation mixtures containing 10e8 M [3H]- 
Table 2 
Binding characteristics of cyclic GMP to a binding protein and a cyclic GMP-dependent cyclic 
GMP phosphodiesterase of D. discoideum 
Atom or atom group Binding to ‘9 Activation b9 Hydrolysis c) Hydrolysis d, 
binding of PDE at 10-a M at 10-e M 
protein 
N’-H + e9 ? + e9 + e9 
N2H2 + + _ - 
N3 ? - - 
ce =o + e) ? + e) + e) 
N7 + + ? + 
2’-OH + + _ 





+ + + 
syn-anti 









a) Derived from Table 1. 
b, Derived from the potency of cyclic GMP derivatives to stimulate the hydrolysis of cyclic 
GMP, shown in Fig. 5. 
‘9 Derived from the potency of cyclic GMP derivatives to inhibit the hydrolysis of cyclic GMP, 
shown in Fig. 5. 
d, Derived from the potency of cyclic GMP derivatives to inhibit the hydrolysis of cyclic GMP, 
shown in Fig. 4. 
e, N1-H and/or ~6 = 0 are/is involved in a binding interaction. +, the atom or atom group is 
directly involved in binding, -, the atom or atom group is not directly involved in binding; ?, 
data from Figs. 4 and 5 are not sufficient to establish the involvement in binding. 
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cyclic GMP shows the capacity of these cyclic nucleotides to activate the phospho- 
disterase (Fig. 5). 8-Br-cGMP and 8-NH2-cGMP activate the hydrolysis of [3H]- 
cGMP even better than cyclic GMP itself; probably because there is less competition 
for hydrolysis. 8-BA-cGMP, 8-M-cGMP and 8-OH-cGMP also activate the hydrolysis 
of [3H] cyclic GMP, but lo-100 times higher concentrations are required. The 
activation at high and not at low concentrations of 8-OH-cGMP may indicate a 
direct interaction at N7. cIMP, cXMP, and 2’-H-cGMP cannot activate cyclic GMP 
hydrolysis, indicating that atomic interactions between cyclic GMP and the activa- 
tor site occur at the N2H2 and 2’-OH positions. At high concentrations these com- 
Fig. 6. Model of the binding site of the cyclic GMP binding protein. We propose that cyclic 
GMP is bound to the binding protein by hydrogen bonds at Nr-H and/or Ce = 0, at N2Hz, 
NY, 2’-OH and 3’-0, and possibly by a charge-charge interaction with the phosphate moiety. 
Interactions at 5’-0 and 4’-0 have not been established. The protein contains atoms or atom 
groups that accept a hydrogen bond (A), that donate a hydrogen bond (D), or that contain a 
positive charge (C’). 
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pounds even start to inhibit hydrolysis of [3H]cylic GMP. The hydrolysis site of 
the enzyme with low activity binds virtually no cyclic GMP at the N2Hz and 2’-OH 
positions. Cyclic AMP does not show activation or inhibition. Because cIMP did not 
show activation, we cannot establish the involvement of N’-H or C6 = 0 in binding 
to the activator site. S’-GMP and guanosine neither activate nor inhibit hydrolysis. 
These specificities are different from those for cyclic GMP-dependent cyclic 
GMP phosphodiesterase found in other organisms [22,23,38]. The enzyme of 
D. discoideum seems to be more specific, so that cyclic AMP has no effect on the 
activity of the enzyme, and the enzyme has no effect on the degradation of cyclic 
AMP in this system. 
Models 
In Table 2 the structural requirements of the cyclic GMP molecule are listed for 
binding to the binding protein, to the activator site of the phosphodiesterase, to the 
hydrolysis site of the phosphodiesterase with low activity and to the hydrolysis 
site of the phosphodiesterase with high activity. 
The specificity of the activator site is similar to the specificity of a cyclic GMP- 
binding protein, except that half-maximal binding occurs at lo-’ M [17], and half- 
maximal activation occurs at about lo-’ M (Fig. 3). A provisional model of the 
interactions of the cyclic GMP-binding protein with cyclic GMP is shown in Fig. 6. 
Binding of cyclic GMP to the hydrolysis site of the activated form of phospho- 
diesterase requires binding to N’-H and/or C6 = 0, to N’, 3’-0, and phosphate. 
Binding of cyclic GMP to the hydrolysis site of the phosphodiesterase with sub- 
maximal activity also requires binding to N’-H and/or C6 = 0,3’-0 and phosphate, 
while binding to N’ is unknown. This similarity of specificity may indicate that 
-activation is due to an increase of I’,,, , rather than a decrease of K,. 
Activation of the enzyme by cyclic GMP and hydrolysis of cyclic GMP show 
different specificities (Table 2), indicating that these processes occur at different 
sites of the enzyme. 
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